UK guidelines for referral and assessment of adults for heart transplantation

Patients with advanced heart failure have a dismal prognosis and poor quality of life. Heart transplantation provides an effective treatment for a subset of these patients. This article provides cardiologists with up-to-date information about referral for transplantation, the role of left ventricular assist devices prior to transplant, patient selection, waiting-list management and donor heart availability. Timing is of central importance; patients should be referred before complications (eg, cardiorenal syndrome or secondary pulmonary hypertension) have developed that will increase the risk of, or potentially contraindicate, transplantation. Issues related to heart failure aetiology, comorbidity and adherence to medical treatment are reviewed. Finally, the positive role that cardiologists can play in promoting and facilitating organ donation is discussed.

[1]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[2]  M. Burch Is heart transplantation for adult congenital heart disease an appropriate use of a scarce resource? , 2010, Heart.

[3]  Robert L Kormos,et al.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  A. Caplan,et al.  Task force 3: Recipient guidelines/prioritization , 1993 .

[5]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[6]  G. Fonarow,et al.  Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.

[7]  T. McDonagh,et al.  N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. , 2003, European heart journal.

[8]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[9]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[10]  J. Parker,et al.  Cardiac resynchronisation therapy: an option for inotrope‐supported patients with end‐stage heart failure? , 2005 .

[11]  Leslie W. Miller,et al.  Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) , 2004, Circulation.

[12]  Jagmeet P. Singh,et al.  Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. , 2008, Journal of the American College of Cardiology.

[13]  Paul Aurora,et al.  Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  M. Lauer,et al.  Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-Blockers , 2005, Circulation.

[15]  Hans L. Hillege,et al.  Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure , 2006, Circulation.

[16]  A. Caplan,et al.  24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. , 1993, Journal of the American College of Cardiology.

[17]  M. Hellmich,et al.  Prognostic impact of NT‐proBNP and renal function in comparison to contemporary multi‐marker risk scores in heart failure patients , 2008, European journal of heart failure.

[18]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[19]  J. Dark,et al.  Smoking After Cardiac Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[21]  Robert L Kormos,et al.  Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  J. Parker,et al.  Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure? , 2005, European Journal of Heart Failure.

[23]  W. S. Ring,et al.  Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. , 2002, Circulation.

[24]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[25]  E. Bartoli,et al.  Blunting of Furosemide Diuresis by Aspirin in Man , 1980, Journal of clinical pharmacology.

[26]  P. Ponikowski,et al.  Effect of anemia on exercise tolerance in chronic heart failure in men. , 2003, The American journal of cardiology.

[27]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[28]  P. Sobotka,et al.  Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. , 2005, Journal of the American College of Cardiology.

[29]  M. Czerny,et al.  Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. , 2007, The Journal of thoracic and cardiovascular surgery.

[30]  J. Neuberger,et al.  Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  H. Scheld,et al.  Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity , 2000, BMJ : British Medical Journal.

[32]  David D. Shin,et al.  Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. , 2007, Archives of internal medicine.

[33]  R. S. Wu,et al.  Clinical outcomes after cardiac transplantation in muscular dystrophy patients. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  Stevenson Lw Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. , 1991 .

[35]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[36]  G. Verleden,et al.  Pretransplant Predictors of Posttransplant Adherence and Clinical Outcome: An Evidence Base for Pretransplant Psychosocial Screening , 2009, Transplantation.

[37]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[38]  J. Townend,et al.  Echocardiography in the Potential Heart Donor , 2010, Transplantation.

[39]  L. Martínez-Dolz,et al.  Study on health-related quality of life in patients with advanced heart failure before and after transplantation. , 2006, Transplantation proceedings.

[40]  W. S. Ring,et al.  Consensus Conference Report , 2002 .

[41]  A. Rigby,et al.  Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure , 2007, European journal of heart failure.

[42]  L. Cooper,et al.  Transplantation for myocarditis: a controversy revisited. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[44]  Kirk R. Kanter,et al.  The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. , 2009, Journal of the American College of Cardiology.

[45]  M. Pfeffer,et al.  Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program , 2009, European journal of heart failure.

[46]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[47]  D. Mancini,et al.  Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[48]  G. Rábago,et al.  Outcomes of Heart Transplantation for Cardiac Amyloidosis: Subanalysis of the Spanish Registry for Heart Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[49]  Wen Cheng,et al.  Use of cardiac allografts with mild and moderate left ventricular hypertrophy can be safely used in heart transplantation to expand the donor pool. , 2008, Journal of the American College of Cardiology.

[50]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[51]  D. Driscoll,et al.  Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. , 1995, Circulation.

[52]  Michael Böhm,et al.  Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology , 2007, European journal of heart failure.

[53]  Michael Böhm,et al.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[54]  J. Schroeder,et al.  Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. , 1996, Journal of the American College of Cardiology.

[55]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[56]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[57]  K. Channon,et al.  Redox state in arterial grafts predicts left ventricular functional restoration after coronary artery bypass grafting , 2008 .

[58]  N. Banner,et al.  Trends in adult heart transplantation: a national survey from the United Kingdom Cardiothoracic Transplant Audit 1995-2007. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[59]  U. Tegtbur,et al.  Health-Related Quality of Life in Long-Term Survivors After Heart and Lung Transplantation: A Prospective Cohort Study , 2010, Transplantation.

[60]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[61]  R. Michler,et al.  Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. , 1997, The Journal of thoracic and cardiovascular surgery.

[62]  Stuart Russell,et al.  Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[63]  N. Banner,et al.  Effect of Heart Transplantation on Survival in Ambulatory and Decompensated Heart Failure , 2008, Transplantation.

[64]  Perry M. Elliott,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[65]  M. Cazzola,et al.  Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. , 2005, European heart journal.

[66]  S. Russell,et al.  Recurrence of cardiac sarcoidosis in a heart transplant recipient. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[67]  L. Stevenson Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[68]  V. Tsang,et al.  Heart transplantation after congenital heart surgery: improving results and future goals. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[69]  C. Irving,et al.  Cardiac transplantation in adults with congenital heart disease , 2010, Heart.

[70]  Magdi H. Yacoub,et al.  Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.

[71]  G. Mudge,et al.  Evaluation for a ventricular assist device: selecting the appropriate candidate. , 2009, Circulation.

[72]  John Concato,et al.  Long-Term Mortality in Cerebrovascular Disease , 2003, Stroke.

[73]  A. Negassa,et al.  Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes , 2007, European journal of heart failure.

[74]  Leslie Saxon,et al.  Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure , 2006, Circulation.

[75]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[76]  D. Mozaffarian,et al.  The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.

[77]  R. Bard Letter regarding article by O'Neill et al, "Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers". , 2005, Circulation.

[78]  S. Russell,et al.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.

[79]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.